About
Technology
Issues
FAQ
Links
Official Page
Adenosine A
2A
receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.